Treatment for HPV-Associated Cervical Cancer: Novel Therapeutic Strategies
A special issue of Pharmaceuticals (ISSN 1424-8247). This special issue belongs to the section "Pharmacology".
Deadline for manuscript submissions: 25 December 2025 | Viewed by 67
Special Issue Editors
Interests: molecular biomedicine; cervical cancer; human papillomavirus; oncogenicity and epidemiology; biomedical research networks; precision medicine; women’s health
Interests: cellular/molecular biology of cancer; cervical cancer; mirnas; resistance to therapy; nanomedicine
Interests: cervical cancer; HPV; genomics; proteomics; bioinformatics of diseases
Interests: cellular/molecular biology of cancer; cervical cancer; biomarkers in cancer; cancer stem cells; nanomedicine
Interests: proteomics in cancer; biomarkers in cancer; cervical cancer; breast cancer; ovarian cancer
Special Issue Information
Dear Colleagues,
Despite efforts in recent decades to enhance cervical cancer (CC) management, it remains one of the leading causes of death among women across the world. This is due to various factors, such as human papillomavirus (HPV) infections, primarily HPV 16 and HPV 18, inadequate screening infrastructure, widespread lack of awareness, and limited access to HPV vaccination. Moreover, intrinsic or extrinsic resistance to treatment further complicates improved patient outcomes.
Recently, there has been greater interest in identifying molecules that serve as biomarkers to facilitate more accurate diagnoses, improve follow-ups, and enhance the efficacy of conventional treatments. Profiling via proteomics, transcriptomics, miRNA, and lncRNA has led to the development of new therapeutic targets. Additionally, the incorporation of new technologies for target silence, drug repositioning, nanotransport, and other strategies is steering conventional therapy toward personalized and precision medicine. Leveraging these cutting-edge technologies and approaches presents an opportunity to reduce the global burden of this preventable malignancy, ultimately improving the lives of women in low- and middle-income countries and beyond.
This Special Issue seeks to garner new research on diverse strategies that can enhance existing traditional treatments for cervical cancer, ensuring high response rates with minimal side effects and ultimately improving patient quality of life. We welcome research articles and reviews that focus on drug discovery, delivery, therapeutic applications, and diagnostic approaches related to cervical cancer.
Prof. Dr. Berenice Illades-Aguiar
Dr. Yazmín Gómez-Gómez
Dr. Marco Antonio Leyva-Vázquez
Prof. Dr. Jorge Organista-Nava
Dr. Olga Lilia Garibay-Cerdenares
Guest Editors
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Pharmaceuticals is an international peer-reviewed open access monthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2900 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Keywords
- cervical cancer
- proteomic
- transcriptomic
- miRNA
- lncRNA
- drug repositioning
- nano-transport
- liposomes and immunoliposomes
Benefits of Publishing in a Special Issue
- Ease of navigation: Grouping papers by topic helps scholars navigate broad scope journals more efficiently.
- Greater discoverability: Special Issues support the reach and impact of scientific research. Articles in Special Issues are more discoverable and cited more frequently.
- Expansion of research network: Special Issues facilitate connections among authors, fostering scientific collaborations.
- External promotion: Articles in Special Issues are often promoted through the journal's social media, increasing their visibility.
- Reprint: MDPI Books provides the opportunity to republish successful Special Issues in book format, both online and in print.
Further information on MDPI's Special Issue policies can be found here.
